Center-Authored Papers

Filters: Author is Ahnen, Dennis J  [Clear All Filters]
2012
Phipps AI, Buchanan DD, Makar KW, Burnett-Hartman AN, Coghill AE, Passarelli MN, Baron JA, Ahnen DJ, Win AK, Potter JD et al..  2012.  BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(10):1792-8. Abstract
2013
2014
2015
Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M et al..  2015.  Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(8):1229-38. Abstract
Provenzale D, Jasperson K, Ahnen DJ, Aslanian H, Bray T, Cannon JA, David DS, Early DS, Erwin D, Ford JM et al..  2015.  Colorectal Cancer Screening, Version 1.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(8):959-68. Abstract
Phipps AI, Ahnen DJ, Cheng I, Newcomb PA, Win AK, Burnett T.  2015.  PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial / Ethnic Minorities with Colorectal Cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(7):1046-51. Abstract
Weisenberger DJ, Levine JA, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, Le Marchand L et al..  2015.  Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(3):512-9. Abstract
Levine JA, Phipps AI, Baron JA, Buchanan DD, Ahnen DJ, Cohen S, Lindor NM, Newcomb PA, Rosty C, Haile RW et al..  2015.  Clinicopathological risk factor distributions for MLH1 promoter region methylation in CIMP positive tumors.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
2016